币安人生 / USDT

币安人生 / USDC

SOLV / BNB

SOLV / USDT

SOLV / TRY

SOLV / USDC

KAITO / TRY

KAITO / USDT

KAITO / USDC

NEAR / USD1

KERNEL / USDT

KERNEL / USDC

KERNEL / TRY

KITE / TRY

KITE / USDT

STO / TRY

STO / USDT

STO / USDC

ONG / USDT

ONG / BTC

HEC INFRA PROJECTS LTD

SEPC LIMITED

SHEEL BIOTECH LIMITED

OMNITECH ENGINEERING LTD

JTL INDUSTRIES LIMITED

WE WIN LIMITED

KRITI INDUSTRIES IND LTD

OSWAL AGRO MILLS LTD

HINDCON CHEMICALS LIMITED

LLOYDS LUXURIES LIMITED

FALCON TECHNO LTD

SUNREST LIFESCIENCE LTD

INDIA VIX

AMIR CHAND JAG KUM (E) L

CONFIDENCE PETRO IND LTD.

RAJ TV NETWORK LTD

KREBS BIOCHEMICALS & IND

CURRENT INFRAPROJECTS LTD

HINDUSTAN OIL EXPLORATION

GANESHA ECOSPHERE LIMITED

Click here to get full coverage on DIVISLAB Outlook for the Week (April 06, 2026 – April 10, 2026) - Equitypandit

DIVISLAB Outlook for the Week (April 06, 2026 – April 10, 2026)  Equitypandit

DIVISLAB Outlook for the Week (April 06, 2026 – April 10, 2026) - Equitypandit

Click here to get full coverage on NSE:DIVISLAB Chartbild von TheChartereds - de.tradingview.com

NSE:DIVISLAB Chartbild von TheChartereds  de.tradingview.com

NSE:DIVISLAB Chartbild von TheChartereds - de.tradingview.com

Click here to get full coverage on What To Expect From Divi's Laboratories Ltd (NSE:DIVISLAB) Q3 20 - GuruFocus

What To Expect From Divi's Laboratories Ltd (NSE:DIVISLAB) Q3 20  GuruFocus

What To Expect From Divi's Laboratories Ltd (NSE:DIVISLAB) Q3 20 - GuruFocus

Click here to get full coverage on Should Weakness in Divi's Laboratories Limited's (NSE:DIVISLAB) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? - simplywall.st

Should Weakness in Divi's Laboratories Limited's (NSE:DIVISLAB) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?  simplywall.st

Should Weakness in Divi's Laboratories Limited's (NSE:DIVISLAB) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? - simplywall.st

Click here to get full coverage on With 49% ownership, Divi's Laboratories Limited (NSE:DIVISLAB) insiders have a lot riding on the company's future - simplywall.st

With 49% ownership, Divi's Laboratories Limited (NSE:DIVISLAB) insiders have a lot riding on the company's future  simplywall.st

With 49% ownership, Divi's Laboratories Limited (NSE:DIVISLAB) insiders have a lot riding on the company's future - simplywall.st

Click here to get full coverage on DIVISLAB: Q3 FY26 consolidated income grew 12% YoY to ₹2,692 crores, with PAT at ₹583 crores - TradingView

DIVISLAB: Q3 FY26 consolidated income grew 12% YoY to ₹2,692 crores, with PAT at ₹583 crores  TradingView

DIVISLAB: Q3 FY26 consolidated income grew 12% YoY to ₹2,692 crores, with PAT at ₹583 crores - TradingView

Click here to get full coverage on Divi’s Laboratories to Close Trading Window Ahead of Q3 FY26 Results - TipRanks

Divi’s Laboratories to Close Trading Window Ahead of Q3 FY26 Results  TipRanks

Divi’s Laboratories to Close Trading Window Ahead of Q3 FY26 Results - TipRanks

Click here to get full coverage on Divis Lab slides after Q1 PAT falls 18% QoQ to Rs 545 cr - Business Standard

Divis Lab slides after Q1 PAT falls 18% QoQ to Rs 545 cr  Business Standard

Divis Lab slides after Q1 PAT falls 18% QoQ to Rs 545 cr - Business Standard

Click here to get full coverage on 2026 an 'inflection year' for Divi's Laboratories; Citi sees 43% upside - CNBC TV18

2026 an 'inflection year' for Divi's Laboratories; Citi sees 43% upside  CNBC TV18

2026 an 'inflection year' for Divi's Laboratories; Citi sees 43% upside - CNBC TV18

Click here to get full coverage on Divi's Laboratories Schedules Board Meeting and Earnings Call on February 11, 2026 - scanx.trade

Divi's Laboratories Schedules Board Meeting and Earnings Call on February 11, 2026  scanx.trade

Divi's Laboratories Schedules Board Meeting and Earnings Call on February 11, 2026 - scanx.trade

Click here to get full coverage on Earnings Not Telling The Story For Divi's Laboratories Limited (NSE:DIVISLAB) - simplywall.st

Earnings Not Telling The Story For Divi's Laboratories Limited (NSE:DIVISLAB)  simplywall.st

Earnings Not Telling The Story For Divi's Laboratories Limited (NSE:DIVISLAB) - simplywall.st

Click here to get full coverage on Divi’s Labs Q3 net profit slips 1% on labour‑code charge; revenue up 12% - TradingView

Divi’s Labs Q3 net profit slips 1% on labour‑code charge; revenue up 12%  TradingView

Divi’s Labs Q3 net profit slips 1% on labour‑code charge; revenue up 12% - TradingView

Click here to get full coverage on Investors Shouldn't Be Too Comfortable With Divi's Laboratories' (NSE:DIVISLAB) Earnings - simplywall.st

Investors Shouldn't Be Too Comfortable With Divi's Laboratories' (NSE:DIVISLAB) Earnings  simplywall.st

Investors Shouldn't Be Too Comfortable With Divi's Laboratories' (NSE:DIVISLAB) Earnings - simplywall.st

Click here to get full coverage on Divi's Laboratories Q3 Consol Net Profit 5.83 Billion Rupees - TradingView

Divi's Laboratories Q3 Consol Net Profit 5.83 Billion Rupees  TradingView

Divi's Laboratories Q3 Consol Net Profit 5.83 Billion Rupees - TradingView

Click here to get full coverage on Divi's Laboratories Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - simplywall.st

Divi's Laboratories Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next  simplywall.st

Divi's Laboratories Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - simplywall.st

Click here to get full coverage on Accumulate Divis Laboratories; target of Rs 6850: Prabhudas Lilladher - TradingView

Accumulate Divis Laboratories; target of Rs 6850: Prabhudas Lilladher  TradingView

Accumulate Divis Laboratories; target of Rs 6850: Prabhudas Lilladher - TradingView

Click here to get full coverage on Divi's Laboratories (NSE:DIVISLAB) shareholders have earned a 17% CAGR over the last five years - simplywall.st

Divi's Laboratories (NSE:DIVISLAB) shareholders have earned a 17% CAGR over the last five years  simplywall.st

Divi's Laboratories (NSE:DIVISLAB) shareholders have earned a 17% CAGR over the last five years - simplywall.st

Click here to get full coverage on Divi's Labs, Lupin, other pharma stocks rise up to 4%; here's why HDFC Securities says sector looks 'attractive' - TradingView

Divi's Labs, Lupin, other pharma stocks rise up to 4%; here's why HDFC Securities says sector looks 'attractive'  TradingView

Divi's Labs, Lupin, other pharma stocks rise up to 4%; here's why HDFC Securities says sector looks 'attractive' - TradingView

Click here to get full coverage on Divi's Laboratories (NSE:DIVISLAB) Seems To Use Debt Quite Sensibly - simplywall.st

Divi's Laboratories (NSE:DIVISLAB) Seems To Use Debt Quite Sensibly  simplywall.st

Divi's Laboratories (NSE:DIVISLAB) Seems To Use Debt Quite Sensibly - simplywall.st

Click here to get full coverage on Most Shareholders Will Probably Agree With Divi's Laboratories Limited's (NSE:DIVISLAB) CEO Compensation - simplywall.st

Most Shareholders Will Probably Agree With Divi's Laboratories Limited's (NSE:DIVISLAB) CEO Compensation  simplywall.st

Most Shareholders Will Probably Agree With Divi's Laboratories Limited's (NSE:DIVISLAB) CEO Compensation - simplywall.st

Click here to get full coverage on Divis Labs rallies 13% in 1 week; What's driving pharma stock? - Business Standard

Divis Labs rallies 13% in 1 week; What's driving pharma stock?  Business Standard

Divis Labs rallies 13% in 1 week; What's driving pharma stock? - Business Standard

Click here to get full coverage on Divi's Labs Q3 Results: Net profit drops marginally to ₹583 crore, total income up 12% - Mint

Divi's Labs Q3 Results: Net profit drops marginally to ₹583 crore, total income up 12%  Mint

Divi's Labs Q3 Results: Net profit drops marginally to ₹583 crore, total income up 12% - Mint

Click here to get full coverage on Trade Setup – MTARTECH, LODHA & DIVISLAB - Moneymunch

Trade Setup – MTARTECH, LODHA & DIVISLAB  Moneymunch

Trade Setup – MTARTECH, LODHA & DIVISLAB - Moneymunch

Click here to get full coverage on divis lab brokerage bullish triggers for uptrend - Zee Business

divis lab brokerage bullish triggers for uptrend  Zee Business

divis lab brokerage bullish triggers for uptrend - Zee Business

Click here to get full coverage on Divis Lab and 5 other CDMO stocks to keep on your radar as US Senate passes Biosecure Act - Trade Brains

Divis Lab and 5 other CDMO stocks to keep on your radar as US Senate passes Biosecure Act  Trade Brains

Divis Lab and 5 other CDMO stocks to keep on your radar as US Senate passes Biosecure Act - Trade Brains

Click here to get full coverage on Divi's Laboratories shares fall 4% after IIFL warns of material risk to earnings - CNBC TV18

Divi's Laboratories shares fall 4% after IIFL warns of material risk to earnings  CNBC TV18

Divi's Laboratories shares fall 4% after IIFL warns of material risk to earnings - CNBC TV18

Click here to get full coverage on Divis Lab Q4 PAT climbs 23% YoY to Rs 662 cr; recommends final dividend of Rs 30/ share - Business Standard

Divis Lab Q4 PAT climbs 23% YoY to Rs 662 cr; recommends final dividend of Rs 30/ share  Business Standard

Divis Lab Q4 PAT climbs 23% YoY to Rs 662 cr; recommends final dividend of Rs 30/ share - Business Standard

Click here to get full coverage on Divis Laboratories Sees Sharp Open Interest Surge Amid Bullish Market Positioning - Markets Mojo

Divis Laboratories Sees Sharp Open Interest Surge Amid Bullish Market Positioning  Markets Mojo

Divis Laboratories Sees Sharp Open Interest Surge Amid Bullish Market Positioning - Markets Mojo

Click here to get full coverage on Divis Lab enters into a LT manufacturing and supply agreement with a global pharma co. - Business Standard

Divis Lab enters into a LT manufacturing and supply agreement with a global pharma co.  Business Standard

Divis Lab enters into a LT manufacturing and supply agreement with a global pharma co. - Business Standard

Click here to get full coverage on Divi's Labs Q2 profit rises 35% YoY to Rs 689 crore; shares slip nearly 4% - Business Today

Divi's Labs Q2 profit rises 35% YoY to Rs 689 crore; shares slip nearly 4%  Business Today

Divi's Labs Q2 profit rises 35% YoY to Rs 689 crore; shares slip nearly 4% - Business Today

Click here to get full coverage on Stock Picks: Sagar Doshi suggests Divis Lab, HCL Tech, Marico shares to buy amid Indo-Pak conflict - Mint

Stock Picks: Sagar Doshi suggests Divis Lab, HCL Tech, Marico shares to buy amid Indo-Pak conflict  Mint

Stock Picks: Sagar Doshi suggests Divis Lab, HCL Tech, Marico shares to buy amid Indo-Pak conflict - Mint

Click here to get full coverage on DIVISLAB Share Price | Divis Laboratories Ltd Stock Analysis & Recommendation - Markets Mojo

DIVISLAB Share Price | Divis Laboratories Ltd Stock Analysis & Recommendation  Markets Mojo

DIVISLAB Share Price | Divis Laboratories Ltd Stock Analysis & Recommendation - Markets Mojo

Click here to get full coverage on Divi’s Labs Q4 Results: Profit up 23% YoY, beats estimates; declares ₹30 dividend - CNBC TV18

Divi’s Labs Q4 Results: Profit up 23% YoY, beats estimates; declares ₹30 dividend  CNBC TV18

Divi’s Labs Q4 Results: Profit up 23% YoY, beats estimates; declares ₹30 dividend - CNBC TV18

Click here to get full coverage on Divis Laboratories Ltd Ranks Among Most Active Stocks with Rs 24,400.43 Lakhs Traded Today - Markets Mojo

Divis Laboratories Ltd Ranks Among Most Active Stocks with Rs 24,400.43 Lakhs Traded Today  Markets Mojo

Divis Laboratories Ltd Ranks Among Most Active Stocks with Rs 24,400.43 Lakhs Traded Today - Markets Mojo

Click here to get full coverage on Divis Laboratories Ltd Sees Rs 63.52 Crores in Total Traded Value Today - Markets Mojo

Divis Laboratories Ltd Sees Rs 63.52 Crores in Total Traded Value Today  Markets Mojo

Divis Laboratories Ltd Sees Rs 63.52 Crores in Total Traded Value Today - Markets Mojo

Click here to get full coverage on Divi's Labs Q2 net profit rises 35%; shares fall 3%, snap six-session winning streak amid profit booking - Moneycontrol.com

Divi's Labs Q2 net profit rises 35%; shares fall 3%, snap six-session winning streak amid profit booking  Moneycontrol.com

Divi's Labs Q2 net profit rises 35%; shares fall 3%, snap six-session winning streak amid profit booking - Moneycontrol.com

Click here to get full coverage on Divi’s Laboratories Q1 Results: Cons net profit rises 27% YoY to Rs 545 crore, revenue up 14% - The Economic Times

Divi’s Laboratories Q1 Results: Cons net profit rises 27% YoY to Rs 545 crore, revenue up 14%  The Economic Times

Divi’s Laboratories Q1 Results: Cons net profit rises 27% YoY to Rs 545 crore, revenue up 14% - The Economic Times

Click here to get full coverage on Citi raises its price target on its top pharma pick, sees a 19% upside on the stock - CNBC TV18

Citi raises its price target on its top pharma pick, sees a 19% upside on the stock  CNBC TV18

Citi raises its price target on its top pharma pick, sees a 19% upside on the stock - CNBC TV18

Click here to get full coverage on Divi’s Laboratories Q4 results: PAT surges 26% YoY, revenue up 12% - The Economic Times

Divi’s Laboratories Q4 results: PAT surges 26% YoY, revenue up 12%  The Economic Times

Divi’s Laboratories Q4 results: PAT surges 26% YoY, revenue up 12% - The Economic Times

Click here to get full coverage on Q2 results: Bajaj Auto, Divis Lab, Hindalco, Trent, Nykaa, Kalyan Jewellers, NALCO, others to declare earnings on Nov 7; check list - Upstox

Q2 results: Bajaj Auto, Divis Lab, Hindalco, Trent, Nykaa, Kalyan Jewellers, NALCO, others to declare earnings on Nov 7; check list  Upstox

Q2 results: Bajaj Auto, Divis Lab, Hindalco, Trent, Nykaa, Kalyan Jewellers, NALCO, others to declare earnings on Nov 7; check list - Upstox

Click here to get full coverage on DIVISLAB Forecast — Price Target — Prediction for 2027 - TradingView

DIVISLAB Forecast — Price Target — Prediction for 2027  TradingView

DIVISLAB Forecast — Price Target — Prediction for 2027 - TradingView

Click here to get full coverage on Divi’s Labs Q1FY26 PAT Jumps 26.7% to ₹545 Cr - hdfcsky.com

Divi’s Labs Q1FY26 PAT Jumps 26.7% to ₹545 Cr  hdfcsky.com

Divi’s Labs Q1FY26 PAT Jumps 26.7% to ₹545 Cr - hdfcsky.com

Click here to get full coverage on Divi's Laboratories Stock Price Forecast. Should You Buy DIVISLAB.NS? - StockInvest.us

Divi's Laboratories Stock Price Forecast. Should You Buy DIVISLAB.NS?  StockInvest.us

Divi's Laboratories Stock Price Forecast. Should You Buy DIVISLAB.NS? - StockInvest.us

Click here to get full coverage on DIVISLAB Stock Price and Chart — NSE:DIVISLAB - TradingView

DIVISLAB Stock Price and Chart — NSE:DIVISLAB  TradingView

DIVISLAB Stock Price and Chart — NSE:DIVISLAB - TradingView

Click here to get full coverage on Divi’s Laboratories shares rally 6% on strong Q4 show; should you buy, sell or hold? - Moneycontrol.com

Divi’s Laboratories shares rally 6% on strong Q4 show; should you buy, sell or hold?  Moneycontrol.com

Divi’s Laboratories shares rally 6% on strong Q4 show; should you buy, sell or hold? - Moneycontrol.com

Click here to get full coverage on Anil Singhvi's Stock Strategy Revealed, Divis Lab, Eternal Futures Target, Stoploss Inside - Zee Business

Anil Singhvi's Stock Strategy Revealed, Divis Lab, Eternal Futures Target, Stoploss Inside  Zee Business

Anil Singhvi's Stock Strategy Revealed, Divis Lab, Eternal Futures Target, Stoploss Inside - Zee Business

Click here to get full coverage on Divi's Lab stock slips on US supply worries - The Economic Times

Divi's Lab stock slips on US supply worries  The Economic Times

Divi's Lab stock slips on US supply worries - The Economic Times

Click here to get full coverage on Top stock recommendations for January 21, 2025 - The Times of India

Top stock recommendations for January 21, 2025  The Times of India

Top stock recommendations for January 21, 2025 - The Times of India

Click here to get full coverage on Divis Laboratories Share Price Today - Live DIVISLAB Stock Price for NSE/BSE - Upstox

Divis Laboratories Share Price Today - Live DIVISLAB Stock Price for NSE/BSE  Upstox

Divis Laboratories Share Price Today - Live DIVISLAB Stock Price for NSE/BSE - Upstox

Click here to get full coverage on Technical Analysis of Divi's Laboratories Limited (NSE:DIVISLAB) - TradingView

Technical Analysis of Divi's Laboratories Limited (NSE:DIVISLAB)  TradingView

Technical Analysis of Divi's Laboratories Limited (NSE:DIVISLAB) - TradingView

Click here to get full coverage on DIVISLAB1! Charts and Quotes - TradingView

DIVISLAB1! Charts and Quotes  TradingView

DIVISLAB1! Charts and Quotes - TradingView

Click here to get full coverage on DIVI S LABORATORIES LTD Option Chain - Live DIVI S LABORATORIES LTD Option Chain Data, OI & Price - Upstox

DIVI S LABORATORIES LTD Option Chain - Live DIVI S LABORATORIES LTD Option Chain Data, OI & Price  Upstox

DIVI S LABORATORIES LTD Option Chain - Live DIVI S LABORATORIES LTD Option Chain Data, OI & Price - Upstox

Click here to get full coverage on Why Divis Lab Share Price is Falling - Equitymaster

Why Divis Lab Share Price is Falling  Equitymaster

Why Divis Lab Share Price is Falling - Equitymaster

Click here to get full coverage on Divi's Labs exits the Nifty and gets a 'buy' recommendation with its highest target - CNBC TV18

Divi's Labs exits the Nifty and gets a 'buy' recommendation with its highest target  CNBC TV18

DIVISLAB

Price Chart

Key Statistics

Technicals

About DIVISLAB

Latest News

DIVISLAB Outlook for the Week (April 06, 2026 – April 10, 2026) - Equitypandit

NSE:DIVISLAB Chartbild von TheChartereds - de.tradingview.com

What To Expect From Divi's Laboratories Ltd (NSE:DIVISLAB) Q3 20 - GuruFocus

Advanced Charts

Top Gainers

Top Losers